Dr Daniel S Woolley, MD | |
145 Hospital Ave, Suite 206, Du Bois, PA 15801-1462 | |
(814) 375-2040 | |
(814) 375-2045 |
Full Name | Dr Daniel S Woolley |
---|---|
Gender | Male |
Speciality | Thoracic Surgery |
Experience | 33 Years |
Location | 145 Hospital Ave, Du Bois, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104879709 | NPI | - | NPPES |
101348670 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | MD-051074-L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cjw Medical Center | Richmond, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cardiac Surgical Associates Llc | 7416012448 | 16 |
News Archive
A novel method of embedding child psychiatric care in an urban pediatrics clinic was found to be feasible and a promising way to increase access to and engagement in psychiatric care among a primarily Latino population, according to new study from Boston Medical Center researchers.
"Twenty years after the central government collapsed," Somalia is facing drought, food insecurity and conflict larger in scale than when famine conditions hit the nation in the 1990s, "[a]nd given the world's limited interest in a major intervention, that is not likely to change anytime soon," the New York Times reports in a news analysis on the situation.
Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that it has initiated a pivotal trial of Dermagraft® in subjects with venous leg ulcers (DEVO-Trial) to assess the product's safety and efficacy in the promotion of healing venous leg ulcers (VLUs). Dermagraft is a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process.
Nektar Therapeutics today announced that results from the Phase 2 clinical trial of NKTR-102 in women with platinum-resistant/refractory ovarian cancer will be presented at the Oral Abstract Session of the Gynecologic Cancer Track during the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
› Verified 4 days ago
Entity Name | Cardiac Surgical Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053556506 PECOS PAC ID: 7416012448 Enrollment ID: O20090209000028 |
News Archive
A novel method of embedding child psychiatric care in an urban pediatrics clinic was found to be feasible and a promising way to increase access to and engagement in psychiatric care among a primarily Latino population, according to new study from Boston Medical Center researchers.
"Twenty years after the central government collapsed," Somalia is facing drought, food insecurity and conflict larger in scale than when famine conditions hit the nation in the 1990s, "[a]nd given the world's limited interest in a major intervention, that is not likely to change anytime soon," the New York Times reports in a news analysis on the situation.
Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that it has initiated a pivotal trial of Dermagraft® in subjects with venous leg ulcers (DEVO-Trial) to assess the product's safety and efficacy in the promotion of healing venous leg ulcers (VLUs). Dermagraft is a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process.
Nektar Therapeutics today announced that results from the Phase 2 clinical trial of NKTR-102 in women with platinum-resistant/refractory ovarian cancer will be presented at the Oral Abstract Session of the Gynecologic Cancer Track during the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daniel S Woolley, MD 100 Hospital Ave, Du Bois, PA 15801-1440 Ph: (814) 375-2040 | Dr Daniel S Woolley, MD 145 Hospital Ave, Suite 206, Du Bois, PA 15801-1462 Ph: (814) 375-2040 |
News Archive
A novel method of embedding child psychiatric care in an urban pediatrics clinic was found to be feasible and a promising way to increase access to and engagement in psychiatric care among a primarily Latino population, according to new study from Boston Medical Center researchers.
"Twenty years after the central government collapsed," Somalia is facing drought, food insecurity and conflict larger in scale than when famine conditions hit the nation in the 1990s, "[a]nd given the world's limited interest in a major intervention, that is not likely to change anytime soon," the New York Times reports in a news analysis on the situation.
Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that it has initiated a pivotal trial of Dermagraft® in subjects with venous leg ulcers (DEVO-Trial) to assess the product's safety and efficacy in the promotion of healing venous leg ulcers (VLUs). Dermagraft is a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process.
Nektar Therapeutics today announced that results from the Phase 2 clinical trial of NKTR-102 in women with platinum-resistant/refractory ovarian cancer will be presented at the Oral Abstract Session of the Gynecologic Cancer Track during the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
› Verified 4 days ago
Dr. Raj Ramanuj Kaushik, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 145 Hospital Ave, Suite 300, Du Bois, PA 15801 Phone: 814-375-2040 Fax: 814-375-2045 | |
Forozan Navid, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 145 Hospital Ave Ste 300, Du Bois, PA 15801 Phone: 814-375-2040 Fax: 814-375-2045 |